Literature DB >> 22562851

Advances in glaucoma treatment and management: neurotrophic agents.

Gerald J Chader1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22562851     DOI： 10.1167/iovs.12-9483n

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN： 0146-0404            Impact factor:   4.799


× No keyword cloud information.
  9 in total

1.  Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogs.

Authors:  R F Boyd; S L Boye; T J Conlon; K E Erger; D G Sledge; I M Langohr; W W Hauswirth; A M Komáromy; S E Boye; S M Petersen-Jones; J T Bartoe
Journal:  Gene Ther       Date:  2016-04-07       Impact factor: 5.250

Review 2.  Neuroprotection for treatment of glaucoma in adults.

Authors:  Dayse F Sena; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2017-01-25

Review 3.  Erythropoietin in Optic Neuropathies: Current Future Strategies for Optic Nerve Protection and Repair.

Authors:  Yi-Fen Lai; Ting-Yi Lin; Pin-Kuan Ho; Yi-Hao Chen; Yu-Chuan Huang; Da-Wen Lu
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

Review 4.  Neuroprotection for treatment of glaucoma in adults.

Authors:  Dayse F Sena; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

5.  Overexpression of Brain-Derived Neurotrophic Factor Protects Large Retinal Ganglion Cells After Optic Nerve Crush in Mice.

Authors:  Liang Feng; Zhen Puyang; Hui Chen; Peiji Liang; John B Troy; Xiaorong Liu
Journal:  eNeuro       Date:  2017-01-17

6.  Neuroprotection Against NMDA-Induced Retinal Damage by Philanthotoxin-343 Involves Reduced Nitrosative Stress.

Authors:  Mohamad Haiqal Nizar Mohamad; Izuddin Fahmy Abu; Muhammad Fattah Fazel; Renu Agarwal; Igor Iezhitsa; Norsham Juliana; Ian R Mellor; Henrik Franzyk
Journal:  Front Pharmacol       Date:  2021-12-14       Impact factor: 5.810

7.  Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells.

Authors:  Henry T Hsueh; Yoo-Chun Kim; Ian Pitha; Matthew D Shin; Cynthia A Berlinicke; Renee Ti Chou; Elizabeth Kimball; Julie Schaub; Sarah Quillen; Kirby T Leo; Hyounkoo Han; Amy Xiao; Youngwook Kim; Matthew Appell; Usha Rai; HyeYoung Kwon; Patricia Kolodziejski; Laolu Ogunnaike; Nicole M Anders; Avelina Hemingway; Joan L Jefferys; Abhijit A Date; Charles Eberhart; Thomas V Johnson; Harry A Quigley; Donald J Zack; Justin Hanes; Laura M Ensign
Journal:  Pharmaceutics       Date:  2021-05-01       Impact factor: 6.321

8.  Recent trends in glaucoma management.

Authors:  Sundaram Natarajan
Journal:  Indian J Ophthalmol       Date:  2013-07       Impact factor: 1.848

9.  Long-Term Protection of Retinal Ganglion Cells and Visual Function by Brain-Derived Neurotrophic Factor in Mice With Ocular Hypertension.

Authors:  Liang Feng; Hui Chen; Ji Yi; John B Troy; Hao F Zhang; Xiaorong Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.